Guard Therapeutics International AB (publ)

OM:GUARD Stock Report

Market Cap: kr301.8m

Guard Therapeutics International Management

Management criteria checks 2/4

Guard Therapeutics International's CEO is Tobias Agervald, appointed in Jan 2019, has a tenure of 5.33 years. total yearly compensation is SEK5.23M, comprised of 32.8% salary and 67.2% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth SEK754.20K. The average tenure of the management team and the board of directors is 3.7 years and 4.6 years respectively.

Key information

Tobias Agervald

Chief executive officer

kr5.2m

Total compensation

CEO salary percentage32.8%
CEO tenure5.3yrs
CEO ownership0.2%
Management average tenure3.7yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

Companies Like Guard Therapeutics International (STO:GUARD) Could Be Quite Risky

Apr 18
Companies Like Guard Therapeutics International (STO:GUARD) Could Be Quite Risky

Guard Therapeutics International (STO:GUARD) Will Have To Spend Its Cash Wisely

Jan 04
Guard Therapeutics International (STO:GUARD) Will Have To Spend Its Cash Wisely

Here's Why Guard Therapeutics International (STO:GUARD) Must Use Its Cash Wisely

Sep 20
Here's Why Guard Therapeutics International (STO:GUARD) Must Use Its Cash Wisely

Guard Therapeutics International (STO:GUARD) Is In A Good Position To Deliver On Growth Plans

Apr 06
Guard Therapeutics International (STO:GUARD) Is In A Good Position To Deliver On Growth Plans

We're Keeping An Eye On Guard Therapeutics International's (STO:GUARD) Cash Burn Rate

Sep 09
We're Keeping An Eye On Guard Therapeutics International's (STO:GUARD) Cash Burn Rate

Here's Why We're A Bit Worried About Guard Therapeutics International's (STO:GUARD) Cash Burn Situation

Feb 19
Here's Why We're A Bit Worried About Guard Therapeutics International's (STO:GUARD) Cash Burn Situation

We're Not Very Worried About Guard Therapeutics International's (STO:GUARD) Cash Burn Rate

Aug 17
We're Not Very Worried About Guard Therapeutics International's (STO:GUARD) Cash Burn Rate

Companies Like Guard Therapeutics International (STO:GUARD) Are In A Position To Invest In Growth

Apr 19
Companies Like Guard Therapeutics International (STO:GUARD) Are In A Position To Invest In Growth

Here's Why We're Watching Guard Therapeutics International's (STO:GUARD) Cash Burn Situation

Jan 04
Here's Why We're Watching Guard Therapeutics International's (STO:GUARD) Cash Burn Situation

CEO Compensation Analysis

How has Tobias Agervald's remuneration changed compared to Guard Therapeutics International's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-kr113m

Sep 30 2023n/an/a

-kr137m

Jun 30 2023n/an/a

-kr146m

Mar 31 2023n/an/a

-kr134m

Dec 31 2022kr5mkr2m

-kr113m

Sep 30 2022n/an/a

-kr95m

Jun 30 2022n/an/a

-kr97m

Mar 31 2022n/an/a

-kr88m

Dec 31 2021kr4mkr2m

-kr82m

Sep 30 2021n/an/a

-kr69m

Jun 30 2021n/an/a

-kr47m

Mar 31 2021n/an/a

-kr44m

Dec 31 2020kr3mkr1m

-kr40m

Sep 30 2020n/an/a

-kr43m

Jun 30 2020n/an/a

-kr39m

Mar 31 2020n/an/a

-kr41m

Dec 31 2019kr4mkr1m

-kr45m

Compensation vs Market: Tobias's total compensation ($USD483.56K) is above average for companies of similar size in the Swedish market ($USD251.23K).

Compensation vs Earnings: Tobias's compensation has increased whilst the company is unprofitable.


CEO

Tobias Agervald (47 yo)

5.3yrs

Tenure

kr5,230,000

Compensation

Mr. Tobias Larsson Agervald has been Chief Executive Officer at Guard Therapeutics International AB (publ) (formerly known as A1M Pharma AB (publ))since January 15, 2019 and served as its Chief Medical Off...


Leadership Team

NamePositionTenureCompensationOwnership
Tobias Agervald
Chief Executive Officer5.3yrskr5.23m0.25%
SEK 754.2k
Karin Botha
Chief Financial Officer3.7yrsno data0.028%
SEK 85.3k
Magnus Gram
C.S.O4.9yrsno datano data
Peter Gilmour
Head of Preclinical Science3.8yrsno datano data
Sara Thuresson
Head of Clinical Operations3yrsno data0.019%
SEK 58.5k
Michael Reusch
Chief Medical Officer2.3yrsno datano data
Torbjorn Larsson
Head of Chemistry2yrsno data0.0020%
SEK 6.0k

3.7yrs

Average Tenure

50yo

Average Age

Experienced Management: GUARD's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lars Hockenstrom
Independent Director4.6yrskr136.00k0.0080%
SEK 24.0k
Johan Bygge
Independent Chairman of the board3yrskr271.00k0.062%
SEK 188.6k
Michael Brownstein
Member of Scientific Boardno datano datano data
Goran Forsberg
Independent Director5yrskr162.00k0.014%
SEK 41.1k
Fredrik Lehmann
Independent Director1.4yrskr7.00kno data
Gunvor Ordeberg
Member of Scientific Boardno datano datano data
Anthony Kettle
Member of Scientific Boardno datano datano data
Christopher Redman
Member of Scientific Boardno datano datano data
Henning Schneider
Member of Scientific Boardno datano datano data
Johannes Hulthe
Independent Director5yrskr162.00k0.063%
SEK 190.6k
József Balla
Member of Scientific Boardno datano datano data

4.6yrs

Average Tenure

60yo

Average Age

Experienced Board: GUARD's board of directors are considered experienced (4.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.